Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Allergy. 2016 Jun 13;71(11):1552–1560. doi: 10.1111/all.12895

FIGURE 2.

FIGURE 2

Immunoglobulin trends for antigen-specific IgE, IgG4, IgA, IgA1, and IgA2 among groups. Responder status defined as passing a DBPCFC after at least 4 weeks off therapy at 22, 36 or 48 months. Graphs show logarithmic mean and SEM for each immunoglobulin measurement. Horizontal axis depicts time in months during the clinical trial.